Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne
NCT ID: NCT02338544
Last Updated: 2016-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1388 participants
OBSERVATIONAL
2015-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne
NCT01220102
Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel
NCT01188538
Long-term Study of Epiduo in Patients With Moderate to Severe Acne
NCT01618773
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes
NCT00907101
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
NCT02651220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The observational study is designed as a multicentre study, covering all parts of Germany. Participating investigators are dermatologists with an adequate patient pool of acne patients. The observation time per patient will up to 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.1% Adapalene / 2.5% Benzoyl peroxide
Epiduo® gel containing 0.1% adapalene + 2.5% benzoyl peroxide dispensed from a pump.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient has been diagnosed with moderate to severe inflammatory acne (Leeds Grade 4-12)
* Chest/back affected allowed, but not required
* Topical therapy of acne with Epiduo® is indicated, the decision about treating the patient with Epiduo® has been made independently from this study
Exclusion Criteria
* Acne inversa
* Acne with preferential manisfestation of microcysts, macrocysts and macrocomedones
* Hypersensitivity to the medication or any of the ingredients
* Other contraindications mentioned in the Epiduo® SPC
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma Laboratorium GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uwe Gieler, Prof. M.D.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Gießen und Marburg GmbH
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PUMP-it
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.